Skip to main content
Log in

Synthesis of NSAIDs–Se derivatives as potent anticancer agents

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

In the present study, a series of NSAIDs–Se derivatives include selenocyanates and diselenides were synthesized and characterized, their anticancer activities against the human cancer cell lines SW480, HeLa, A549, and HepG2 were determined. Interestingly, most of the new compounds showed active in reducing the viability of different cancer lines. Compounds 1a and 1m exhibited higher promising activities than other derivatives. As the most active compound 1a showed IC50 values lower than 20 μM against the four cancer cell lines, particularly against SW480 with IC50 values below 10 μm, it shows the potential to be a promising molecular chemotherapeutic agent for colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1

Similar content being viewed by others

References

  • Agrawal A, Fentiman IS (2008) NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract 62:444–449

    Article  PubMed  CAS  Google Scholar 

  • Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC, Murray MD (2012) Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord 12:93

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Arafa SA, Abdelazeem AH, Arab HH, Omar HA (2014) OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro. Acta Pharmacol Sin 35:394–400

    Article  PubMed Central  CAS  Google Scholar 

  • Baines A, Taylor-Parker M, Goulet AC, Renaud C, Gerner EW, Nelson MA (2002) Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines. Cancer Biol Ther 1:370–374

    Article  PubMed  CAS  Google Scholar 

  • Bodnar M, Konieczka P, Namiesnik J (2012) The properties, functions, and use of selenium compounds in living organisms. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 30:225–252

    Article  CAS  Google Scholar 

  • Chan AT, Manson JE, Feskanich D, Stampfer MJ, Colditz GA, Fuchs CS (2007) Long-term aspirin use and mortality in women. Arch Intern Med 167:562–572

    Article  PubMed  Google Scholar 

  • Desai D, Sinha I, Null K, Wolter W, Suckow MA, King T, Amin S, Sinha R (2010) Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells. Int J Cancer 127:230–238

    Article  PubMed  CAS  Google Scholar 

  • Fernandes AP, Gandin V (2015) Selenium compounds as therapeutic agents in cancer. Biochim Biophys Acta 1850:1642–1660

    Article  PubMed  CAS  Google Scholar 

  • Ghose A, Fleming J, El-Bayoumy K, Harrison PR (2001) Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res 61:7479–7487

    PubMed  CAS  Google Scholar 

  • Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sorensen HT (2012) Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study. Cancer 118:4768–4776

    Article  PubMed  CAS  Google Scholar 

  • Kontogiorgis CA, Hadjipavlou-Litina DJ (2002) Non steroidal anti-inflammatory and anti-allergy agents. Curr Med Chem 9:89–98

    Article  PubMed  CAS  Google Scholar 

  • Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC (2006) Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 66:1070–1075

    Article  PubMed  CAS  Google Scholar 

  • Omar HA, Arafa SA, Maghrabi IA, Weng JR (2014) Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor. Basic Clin Pharmacol Toxicol 114:464–471

    Article  PubMed  CAS  Google Scholar 

  • Pinto JT, Sinha R, Papp K, Facompre ND, Desai D, El-Bayoumy K (2007) Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Int J Cancer 120:1410–1417

    Article  PubMed  CAS  Google Scholar 

  • Plano D, Baquedano Y, Moreno-Mateos D, Font M, Jimenez-Ruiz A, Palop JA, Sanmartin C (2011) Selenocyanates and diselenides: a new class of potent antileishmanial agents. Eur J Med Chem 46:3315–3323

    Article  PubMed  CAS  Google Scholar 

  • Plano D, Karelia DN, Pandey MK, Spallholz JE, Amin S, Sharma AK (2016) Design, synthesis, and biological evaluation of novel selenium (Se-NSAID) molecules as anticancer agents. J Med Chem 59:1946–1959

    Article  PubMed  CAS  Google Scholar 

  • Poerschke RL, Franklin MR, Moos PJ (2008) Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid. Toxicol In Vitro 22:1761–1767

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z, Meade TW (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379:1602–1612

    Article  PubMed  CAS  Google Scholar 

  • Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomized trials. Lancet 376:1741–1750

    Article  PubMed  CAS  Google Scholar 

  • Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, Ray KK (2012) Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med 172:209–216

    Article  PubMed  CAS  Google Scholar 

  • Sharma AK, Sharma A, Desai D, Madhunapantula SV, Huh SJ, Robertson GP, Amin S (2008) Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. J Med Chem 51:7820–7826

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM (2000) 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst 92:1136–1142

    Article  PubMed  CAS  Google Scholar 

  • Ulrich CM, Bigler J, Potter JD (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6:130–140

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This investigation was made possible through the financial support of National Natural Science Foundation of China (Grant No: 21302065).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xianran He.

Ethics declarations

Conflict of interest

We declare that we have no financial and personal relationships with other people or organizations that caninappropriately influence our work, there is no professional or other personal interest of any nature or kind inany product, service and/or company that could be construed as influencing the position presented in, or thereview of, the manuscript entitled “Synthesis of NSAIDs–Se derivatives as potent anticancer agents”.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, l., Li, S., Li, X. et al. Synthesis of NSAIDs–Se derivatives as potent anticancer agents. Med Chem Res 27, 2071–2078 (2018). https://doi.org/10.1007/s00044-018-2216-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-018-2216-7

Keywords

Navigation